Verhoef LM, den Broeder N, Thurlings, et al. Ultra-low doses of rituximab or retreatment of rheumatoid arthritis: a randomised controlled non-inferiority trial. EULAR 2019; Madrid: Abstract LB0010.
Cardiovasculair risico bij reumapatiënten behandeld met biologicals of tofacitinib
mrt 2018 | Arthritis psoriatica, JIA, RA, Spondyloartritis